Delivery Order SPE2DB24D1205-SPE2DB25FCWDQ
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Orencia 250 mg vials, a biologic immunosuppressant medication used primarily for rheumatoid arthritis treatment. This firm fixed price delivery order, valued at $6,942.46, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by August 26, 2025. The award was placed with AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order is valued at $13,647.57 with an ultimate completion date of September 17, 2025. The contract carries no set-aside designation and was competitively awarded through the federal procurement process. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,855.88 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, a biologic medication commonly used to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 23, 2025, and represents performance from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency has awarded a delivery order valued at $17,135.28 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price, competitively awarded contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is unencumbered by...
- The Defense Logistics Agency awarded a delivery order valued at $7,139.70 to AmerisourceBergen Drug Corp for 250 mg vials of Orencia, a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions. Issued on August 4, 2025, with an ultimate completion date of August 5, 2025, this firm fixed-price delivery order was awarded competitively without set-aside restrictions. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,290.07 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award...
- The Defense Logistics Agency awarded a delivery order valued at $6,937.20 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a firm fixed-price procurement with no set-aside designation. The contract was competitively awarded and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $13,069.86 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Orencia Clickject 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 9, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside...
- The Defense Logistics Agency awarded a $53,090.30 delivery order to AmerisourceBergen Drug Corp for 250 mg vials of Orencia, a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive set-aside contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,316.24 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, a biologic medication used primarily for rheumatoid arthritis treatment. The contract was awarded on May 8, 2025, with an ultimate completion date of May 9, 2025, and utilizes firm fixed pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCWDQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Orencia 250 mg vials, a biologic medication used primarily for rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, valued at $5,478.63, is scheduled for completion by April 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal medical procurement requirements through open competition. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. This prime IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The current award represents a routine fulfillment under this expansive contract vehicle, supporting the federal government's medical supply chain for defense-related healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 4/24/25 |